Ajanta Pharma USA Inc: Aripiprazole Tablets Usp

Aripiprazole Tablets Recall Summary Ajanta Pharma USA Inc. is recalling bottles of Aripiprazole Tablets USP 30 mg (NDC 27241-056-03) distributed nationwide because some bottles were mislabeled and actually contain Voriconazole Tablets 50 mg instead. This mix-up affects patients who received this medication in all 50 states and Washington, D.C. Taking the wrong medication could cause serious health problems.

Recalling firm
Ajanta Pharma USA Inc
Product
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Reason
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-05-27
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
U.S. Nationwide

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/1d86ba2d-bbaa-41e5-87f5-593160a24a38